Home › Stocks › NYMXF

NYMXF — NYMOX PHARMACEUTICAL CORP COM

Reported value held$77.96K
Funds holding (latest)14
Sector—

What is a 13F filing? Who files one and when · What 13F filings can't tell you

Funds holding (Q2 2026)1
Institutional value$4.21K · 35.10K sh
New / Add / Cut / Exit0 / 0 / 0 / 0 · Updated 2026-10-24
Top-5 / Top-10 concentration100.0% / 100.0%
Institutional holdings change Accumulating +0.0% (+0 sh)
Institutional value change Up +71.4%

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

As of Q2 2026, 1 SEC-registered investment managers reported holding NYMXF (NYMOX PHARMACEUTICAL CORP COM) in their latest 13F filings, with a combined reported value of $4.21K across 35.10K shares. That is +0.0% by share count (+0 shares) versus the previous quarter, while reported value moved +71.4%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.

Major shareholders of NYMOX PHARMACEUTICAL CORP COM (NYMXF) include Morgan Stanley, Renaissance Technologies, DF DENT & CO INC, ranked by reported 13F value among the 14 institutional holders on this page.

All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.

Institutional Ownership by Quarter

Quarter Funds holding Shares Value QoQ Net Change
Q3 2026 1 35.10K $1.25K +0.0%
Q2 2026 1 35.10K $4.21K +0.0%
Q1 2026 1 35.10K $2.46K +0.0%
Q4 2025 1 35.10K $1.41K +0.0%
Q3 2025 1 35.10K $2.06K +0.0%
Q2 2025 1 35.10K $4.13K +0.0%
Q1 2025 2 110.10K $15.96K +0.0%
Q4 2024 1 35.10K $3.51K +0.0%

Over the 8 quarters shown, institutional share counts increased 0% in aggregate (Q4 2024 → Q3 2026).

Top Institutional Holders (Q3 2026) — 1 funds

FundSharesValuePortfolio WeightChange
First Citizens Financial Corp 35.10K $1.25K 0.00% Hold

↑ Back to the top of the holders list

Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders

Q2 2026 — 1 funds

FundSharesValuePortfolio WeightChange
First Citizens Financial Corp 35.10K $4.21K 0.00% Hold

Q1 2026 — 1 funds

FundSharesValuePortfolio WeightChange
First Citizens Financial Corp 35.10K $2.46K 0.00% Hold

Q4 2025 — 1 funds

FundSharesValuePortfolio WeightChange
First Citizens Financial Corp 35.10K $1.41K 0.00% Hold

Q3 2025 — 1 funds

FundSharesValuePortfolio WeightChange
First Citizens Financial Corp 35.10K $2.06K 0.00% Hold

Q2 2025 — 1 funds

FundSharesValuePortfolio WeightChange
First Citizens Financial Corp 35.10K $4.13K 0.00% Hold

New Positions (Q2 2026)

No fund opened a new position this quarter.

Fully Exited (vs previous quarter)

No tracked fund fully exited this quarter.

Fund Position History — shares by quarter (top 14 funds)

FundQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
First Citizens Financial Corp 35.10K 35.10K 35.10K 35.10K 35.10K 35.10K 35.10K 35.10K 35.10K 35.10K 35.10K 35.10K 35.10K — — — — — — —
DF DENT & CO INC — — — — — — 75.00K — 75.00K — 75.00K — 75.00K — — — — — — —
Renaissance Technologies — — — — — — — — — — — — — 60.80K 69.38K 82.80K — 19.74K — —
Wells Fargo & Co — — — — — — — — — — — — — 3.30K 3.30K 3.10K 14.49K — — 7.48K
One Day In July LLC — — — — — — — — — — — — 10.00K — — — — — — —
Bank of America Corp — — — — — — — — — — — — — 708 708 354 1.27K 3.25K 9.40K 15.12K
Citigroup Inc — — — — — — — — — — — — — — — — — 1.47K 109.08K —
Geode Capital Management — — — — — — — — — — — — — 50.68K 50.68K 50.68K 50.68K 50.68K 50.68K 50.68K
Millennium Management — — — — — — — — — — — — — — 47.92K — 38.07K — — 21.88K
UBS Group AG — — — — — — — — — — — — — 34.53K 375 375 375 925 550 550
Citadel Advisors — — — — — — — — — — — — — 30.14K 72.71K 99.96K — — 24.94K —
Goldman Sachs Group — — — — — — — — — — — — — 22.08K 19.98K 19.98K 21.22K 23.78K 23.91K 24.38K
Morgan Stanley — — — — — — — — — — — — — 98.69K 98.69K 97.62K 96.57K 66.42K 68.27K 67.10K
JPMorgan Chase & Co — — — — — — — — — — — — — 10.22K 7.74K 9.36K 9.64K 9.26K 11.45K 12.08K

Download holders (CSV)

FAQ

Which funds hold NYMXF?

As of 2026-Q2, 1 institutional funds reported holding NYMXF (NYMOX PHARMACEUTICAL CORP COM) in SEC 13F filings, with a combined reported value of $4.21K.

How many shares of NYMXF do institutions own?

13F filers reported 35.10K shares of NYMXF, worth $4.21K in aggregate at the end of 2026-Q2.

Is institutional ownership of NYMXF rising or falling?

Share counts moved +0.0% versus the prior quarter — accumulation.

Who are the top institutional holders of NYMXF?

The largest 13F holders are Morgan Stanley, Renaissance Technologies, DF DENT & CO INC, Geode Capital Management, UBS Group AG; the top 25 are ranked at the top of this page.

Who are the major shareholders of NYMOX PHARMACEUTICAL CORP COM?

The major shareholders of NYMOX PHARMACEUTICAL CORP COM (NYMXF) by reported 13F value are Morgan Stanley, Renaissance Technologies, DF DENT & CO INC, Geode Capital Management, UBS Group AG, among 14 institutional holders.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

Embed this stock on your site

Copy the snippet below to show a live "which legendary investors own NYMXF" list on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/stocks/NYMXF/widget" width="100%" height="640" frameborder="0" loading="lazy" title="HoldingsHub stock holders"></iframe>

Preview the embeddable widget →